A breakthrough new approach for the treatment of Alzheimer's disease



Appointments, information, and physician referrals: (310) 824-6199 Mon-Fri 8AM-6PM


as seen in Nature Clinical Practice Neurology, in a university press release, on Medscape, the BBC, New Scientist, CNN, Fox News, ABC News, Bloomberg News, Reuters Health, the Times Online (U.K.), the Daily Telegraph(U.K.), and UPI.


INR 100 UCLA Medical Plaza, Suites 205-210 Los Angeles (310) 824-6199 Orange County: 361 Hospital Road, Suite 428 Newport Beach

Copyright ©2010, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. Perispinal etanercept for Alzheimer's disease and other forms of dementia is a patented[1], off-label treatment method developed at the INR. [1]U.S. patents 6,537,549; 6,982,089; 7,214,658; 7,629,311; Australian patent 758,523; and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Please see the medical and legal disclaimer.
<Map and Directions><Appointments><Physician Training Program><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Videos>